4//SEC Filing
NPS PHARMACEUTICALS INC 4
Accession 0001235645-05-000004
CIK 0000890465operating
Filed
Apr 18, 8:00 PM ET
Accepted
Apr 19, 4:17 PM ET
Size
10.2 KB
Accession
0001235645-05-000004
Insider Transaction Report
Form 4
MUELLER ALAN L
VP, Drug Discovery
Transactions
- Award
Non-Qualified Stock Option
2005-04-15$12.97/sh+6,348$82,334→ 6,348 totalExercise: $12.97From: 2006-04-15Exp: 2015-04-15→ Common Stock (6,348 underlying) - Award
Incentive Stock Option
2005-04-15$12.97/sh+2,527$32,775→ 2,527 totalExercise: $12.97From: 2006-04-15Exp: 2015-04-15→ Common Stock (2,527 underlying) - Award
Incentive Stock Option
2005-04-15$12.97/sh+438$5,681→ 438 total(indirect: By Spouse)Exercise: $12.97From: 2006-04-15Exp: 2015-04-15→ Common Stock (438 underlying)
Footnotes (1)
- [F1]Stock option granted under the 1998 Stock Option Plan. The option becomes exercisable based on the following four-year vesting schedule: 28% on the first anniversary of the grant, and 2% each month thereafter.
Documents
Issuer
NPS PHARMACEUTICALS INC
CIK 0000890465
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000890465
Filing Metadata
- Form type
- 4
- Filed
- Apr 18, 8:00 PM ET
- Accepted
- Apr 19, 4:17 PM ET
- Size
- 10.2 KB